Pertussis vaccine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Pertussis vaccine
Accession Number
DB15274
Type
Biotech
Groups
Approved, Investigational
Description

Pertussis vaccine is under investigation in clinical trial NCT01698346 (Pertussis (Tdap) Vaccination in Pregnancy).

Synonyms
  • Bordetella pertussis
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Pertussis Vaccine 4 Protect UnitSuspension15000 mSubcutaneousAventis Pasteur Limited1921-12-312001-07-19Canada
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Diphtheria and Tetanus Toxoids With Pertussis Vaccine AdsorbedPertussis vaccine (12 unit) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 lf) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (25 lf)LiquidIntramuscularAventis Pasteur Limited1980-12-312001-07-19Canada
Tri-immunol Liq ImPertussis vaccine (4 unit) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 lf) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (12.5 lf)LiquidIntramuscularLederle Labs, Division of American Cyanamid Co1993-12-312001-06-05Canada
Categories
UNII
2QNL82089R
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
2-MethoxyethanolThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with 2-Methoxyethanol.
25-desacetylrifapentineThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with 25-desacetylrifapentine.
6-Deoxyerythronolide BThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with 6-Deoxyerythronolide B.
9-(N-methyl-L-isoleucine)-cyclosporin AThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with 9-(N-methyl-L-isoleucine)-cyclosporin A.
AbataceptThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Abatacept.
AbetimusThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Abetimus.
Acetic acidThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Acetic acid.
Acetyl sulfisoxazoleThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Acetyl sulfisoxazole.
ActeosideThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Acteoside.
AdalimumabThe therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Adalimumab.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Pertussis_vaccine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingPreventionPertussis / Pregnancy1
4CompletedPreventionDiphtheria / Pertussis / Tetanus / Whooping Cough1
4CompletedPreventionPregnancy1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
LiquidIntramuscular
SuspensionSubcutaneous15000 m
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 09:06 / Updated on May 28, 2019 20:08